- Home
- HRTX vs HVII Comparison
HRTX vs HVII Comparison
Compare HRTX & HVII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- HVII
- Stock Information
- Founded
- HRTX 1983
- HVII 2024
- Country
- HRTX United States
- HVII United States
- Employees
- HRTX N/A
- HVII N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- HVII
- Sector
- HRTX Health Care
- HVII
- Exchange
- HRTX Nasdaq
- HVII NYSE
- Market Cap
- HRTX 270.7M
- HVII 259.2M
- IPO Year
- HRTX 1987
- HVII 2025
- Fundamental
- Price
- HRTX $2.11
- HVII $9.87
- Analyst Decision
- HRTX Strong Buy
- HVII
- Analyst Count
- HRTX 3
- HVII 0
- Target Price
- HRTX $5.67
- HVII N/A
- AVG Volume (30 Days)
- HRTX 1.6M
- HVII 85.9K
- Earning Date
- HRTX 05-06-2025
- HVII 01-01-0001
- Dividend Yield
- HRTX N/A
- HVII N/A
- EPS Growth
- HRTX N/A
- HVII N/A
- EPS
- HRTX N/A
- HVII N/A
- Revenue
- HRTX $144,285,000.00
- HVII N/A
- Revenue This Year
- HRTX $11.81
- HVII N/A
- Revenue Next Year
- HRTX $15.79
- HVII N/A
- P/E Ratio
- HRTX N/A
- HVII N/A
- Revenue Growth
- HRTX 13.57
- HVII N/A
- 52 Week Low
- HRTX $1.04
- HVII $9.81
- 52 Week High
- HRTX $3.93
- HVII $9.90
- Technical
- Relative Strength Index (RSI)
- HRTX 44.61
- HVII N/A
- Support Level
- HRTX $2.32
- HVII N/A
- Resistance Level
- HRTX $2.46
- HVII N/A
- Average True Range (ATR)
- HRTX 0.14
- HVII 0.00
- MACD
- HRTX -0.05
- HVII 0.00
- Stochastic Oscillator
- HRTX 2.17
- HVII 0.00
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About HVII HENNESSY CAPITAL INVESTMENT CORP VI
Hennessy Capital Investment Corp VII is a blank check company.